These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29179455)

  • 21. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo.
    Zhong X; Lin J; Zhou J; Xu W; Hong Z
    Mol Med Rep; 2015 Aug; 12(2):1699-708. PubMed ID: 25825141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation.
    Ropiquet F; Giri D; Lamb DJ; Ittmann M
    J Urol; 1999 Aug; 162(2):595-9. PubMed ID: 10411093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
    Giri D; Ittmann M
    Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C; Luo F; Zhou Y; Du X; Shi J; Zhao X; Xu Y; Zhu Y; Hong W; Zhang J
    Exp Cell Res; 2016 Jul; 345(2):125-33. PubMed ID: 25849092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.
    Boudon C; Rodier G; Lechevallier E; Mottet N; Barenton B; Sultan C
    J Clin Endocrinol Metab; 1996 Feb; 81(2):612-7. PubMed ID: 8636277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.
    Rick FG; Schally AV; Block NL; Abi-Chaker A; Krishan A; Szalontay L
    Prostate; 2013 Jun; 73(8):873-83. PubMed ID: 23280565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress promotes benign prostatic hyperplasia.
    Vital P; Castro P; Ittmann M
    Prostate; 2016 Jan; 76(1):58-67. PubMed ID: 26417670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between molecular biomarkers and risk factors for the clinical progression of benign prostatic hyperplasia using tissue microarray immunostaining.
    Ma D; Yang B; Zhou Z; Pan D; Zhang X
    Chin Med J (Engl); 2014; 127(23):4031-5. PubMed ID: 25430444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-gamma and its functional receptors overexpression in benign prostatic hyperplasia and prostatic carcinoma: parallelism with c-myc and p53 expression.
    Royuela M; de Miguel MP; Ruiz A; Fraile B; Arenas MI; Romo E; Paniagua R
    Eur Cytokine Netw; 2000 Mar; 11(1):119-27. PubMed ID: 10705309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.
    Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ
    J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia.
    Bechis SK; Otsetov AG; Ge R; Wang Z; Vangel MG; Wu CL; Tabatabaei S; Olumi AF
    J Urol; 2015 Oct; 194(4):1031-7. PubMed ID: 25916673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
    Nassis L; Frauman AG; Ohishi M; Zhuo J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and risk of treatment for benign prostatic hyperplasia in Japanese men: a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    Int J Urol; 2013 Jan; 20(1):100-6. PubMed ID: 23106204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of cell proliferation through a KIT-mediated mechanism in benign prostatic hyperplasia.
    Imura M; Kojima Y; Kubota Y; Hamakawa T; Yasui T; Sasaki S; Hayashi Y; Kohri K
    Prostate; 2012 Oct; 72(14):1506-13. PubMed ID: 22314612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular senescence in the pathogenesis of benign prostatic hyperplasia.
    Castro P; Giri D; Lamb D; Ittmann M
    Prostate; 2003 Apr; 55(1):30-8. PubMed ID: 12640658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
    Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T
    Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
    J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia.
    Vikram A; Jena GB; Ramarao P
    Prostate; 2010 Jan; 70(1):79-89. PubMed ID: 19790233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.